ASCO24: Novartis Leukemia Drug Beats Older Drugs in Phase III Readout
Updated: 2024-05-31 15:02:54
Published: May 31, 2024 By Kate Goodwin Pictured: Novartis’ logo outside its building in San Diego, California/iStock, JHVEPhoto Novartis’ kinase inhibitor Scemblix aced a Phase III trial in chronic myeloid leukemia, as the Swiss pharma looks [...]